ACAD
40.42
+0.2
+0.50%
AEMD
8.7
-0.15
-1.69%
APRI
1.57
+0.07
+4.67%
ARNA
4.15
-0.05
-1.19%
ATEC
1.353
+0.003
+0.1852%
CNAT
5.3
-0.02
-0.38%
CRXM
0.5
0.00
0.00%
CYTX
0.649
-0.032
-4.7437%
DXCM
68.09
-0.16
-0.23%
GNMK
9.05
+0.02
+0.22%
HALO
17.05
-0.2
-1.16%
ILMN
203.94
+0.82
+0.40%
INNV
0.153
+0.003
+1.6667%
INO
8.32
+0.06
+0.73%
ISCO
0.05
0.00
0.00%
ISIS
67.425
+0.255
+0.380%
LGND
89.67
+0.44
+0.49%
LPTN
0.303
+0.006
+2.020%
MBVX
2.26
-0.12
-5.04%
MEIP
1.896
-0.014
-0.733%
MNOV
4.012
+0.012
+0.300%
MRTX
26.23
+0.39
+1.51%
MSTX
0.496
-0.009
-1.7624%
NBIX
43.32
+1.34
+3.19%
NUVA
48.13
-0.1
-0.21%
ONCS
0.233
0.00
0.00%
ONVO
4.66
-0.02
-0.43%
OREX
4.99
-0.01
-0.20%
OTIC
24.05
-7
-22.54%
QDEL
22
-0.73
-3.21%
RCPT
159.48
-0.63
-0.39%
RGLS
12.67
-0.08
-0.63%
RMD
57.26
-0.06
-0.10%
SCIE
0.015
0.00
0.00%
SPHS
0.87
+0.01
+1.28%
SRNE
13.02
-0.19
-1.44%
TROV
10.67
+0.38
+3.69%
VICL
0.91
+0.02
+2.2360%
VOLC
17.99
0.00
0.00%
ZGNX
1.39
-0.01
-0.7071%
ACAD
40.42
+0.2
+0.50%
AEMD
8.7
-0.15
-1.69%
APRI
1.57
+0.07
+4.67%
ARNA
4.15
-0.05
-1.19%
ATEC
1.353
+0.003
+0.1852%
CNAT
5.3
-0.02
-0.38%
CRXM
0.5
0.00
0.00%
CYTX
0.649
-0.032
-4.7437%
DXCM
68.09
-0.16
-0.23%
GNMK
9.05
+0.02
+0.22%
HALO
17.05
-0.2
-1.16%
ILMN
203.94
+0.82
+0.40%
INNV
0.153
+0.003
+1.6667%
INO
8.32
+0.06
+0.73%
ISCO
0.05
0.00
0.00%
ISIS
67.425
+0.255
+0.380%
LGND
89.67
+0.44
+0.49%
LPTN
0.303
+0.006
+2.020%
MBVX
2.26
-0.12
-5.04%
MEIP
1.896
-0.014
-0.733%
MNOV
4.012
+0.012
+0.300%
MRTX
26.23
+0.39
+1.51%
MSTX
0.496
-0.009
-1.7624%
NBIX
43.32
+1.34
+3.19%
NUVA
48.13
-0.1
-0.21%
ONCS
0.233
0.00
0.00%
ONVO
4.66
-0.02
-0.43%
OREX
4.99
-0.01
-0.20%
OTIC
24.05
-7
-22.54%
QDEL
22
-0.73
-3.21%
RCPT
159.48
-0.63
-0.39%
RGLS
12.67
-0.08
-0.63%
RMD
57.26
-0.06
-0.10%
SCIE
0.015
0.00
0.00%
SPHS
0.87
+0.01
+1.28%
SRNE
13.02
-0.19
-1.44%
TROV
10.67
+0.38
+3.69%
VICL
0.91
+0.02
+2.2360%
VOLC
17.99
0.00
0.00%
ZGNX
1.39
-0.01
-0.7071%
Home » Archive by Category

SDBN Feed

BIO 2009: Stem Cell Companies’ ‘Fate’ Relies on Interdisciplinary Business Models

May 19, 2009 – 10:59 am

I attended the ‘Mastering Your (Cell) Fate: Stem Cells, iPSCs and the Future of Medicine’ session at BIO on Monday, which featured a panel of specialists: G. Steven Burrill, CEO, Burrill & Company, Aaron Rowe, …

BIO 2009: Stem Cell Companies’ ‘Fate’ Relies on Interdisciplinary Business Models

May 19, 2009 – 10:59 am

I attended the ‘Mastering Your (Cell) Fate: Stem Cells, iPSCs and the Future of Medicine’ session at BIO on Monday, which featured a panel of specialists: G. Steven Burrill, CEO, Burrill & Company, Aaron Rowe, …

BIO 2009: Stem Cell Companies’ ‘Fate’ Relies on Interdisciplinary Business Models

May 19, 2009 – 10:59 am

I attended the ‘Mastering Your (Cell) Fate: Stem Cells, iPSCs and the Future of Medicine’ session at BIO on Monday, which featured a panel of specialists: G. Steven Burrill, CEO, Burrill & Company, Aaron Rowe, …

BIO 2009: Stem Cell Companies’ ‘Fate’ Relies on Interdisciplinary Business Models

May 19, 2009 – 10:59 am

I attended the ‘Mastering Your (Cell) Fate: Stem Cells, iPSCs and the Future of Medicine’ session at BIO on Monday, which featured a panel of specialists: G. Steven Burrill, CEO, Burrill & Company, Aaron Rowe, …

BIO 2009: Stem Cell Companies’ ‘Fate’ Relies on Interdisciplinary Business Models

May 19, 2009 – 10:59 am

I attended the ‘Mastering Your (Cell) Fate: Stem Cells, iPSCs and the Future of Medicine’ session at BIO on Monday, which featured a panel of specialists: G. Steven Burrill, CEO, Burrill & Company, Aaron Rowe, …

Good Morning from BIO!

May 18, 2009 – 4:44 am

You may know I’m a blogger at the Biotechnology Industry Organization convention in Atlanta. I’m here and adjusting to the time change. I’m eager to cover stories about San Diego Biotech–we’ve got a lot going …

See you tonight–50+ Companies Represented!

April 30, 2009 – 8:59 am

Looking forward to seeing everyone tonight. We’ll have onsite registration ($25, $20 for academics with ID), so feel free to stop by. You’ll be able to network with people from 50+ companies at the event, …

Seven Ways To Use The SDBN More Effectively

April 17, 2009 – 10:00 am

The San Diego Biotechnology Network is a next generation organization dedicated to helping people connect better than ever before. What makes it different? Well, for starters, members can interact easily both online and face to …

Pictures From Our March 18th Event Now Available

April 9, 2009 – 7:18 am

Pictures from our March 18th SDBN event featuring Milo Shapiro from IMPROVentures are now posted on Flickr. Special thanks to Richard Ludwig of California BioSolutions for being our photographer! The photos showcase our new venue, …

Regulus Therapeutics to be Featured at April 30th Event

March 29, 2009 – 10:18 am

SDBN’s April event will feature Regulus Therapeutics, an exciting new company focused on the development and commercialization of microRNA therapeutics. SDBN events are the only place you can learn about the hottest scientific research in …